Glioblasztóma: vizsgálatok itt: Dél-Korea

In Dél-Korea 7 Also abroad 424

7 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

No phaseNot yet taking people in Dél-Korea
Safety and Efficacy of Autologous Natural Killer Cell Therapy (CHANK-101) in Patients With Recurrent Glioblastoma
Where
Busan, Seongnam-si, Seoul
Életkor
19 év to 69 év
People
60
Run by
Dong-A University Hospital
See details and how to joinNCT07831161
1/2. fázisTaking people
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Where
Seoul
Életkor
Up to 25 év
People
75 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00
1. fázisTaking people
A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
Where
Seongnam
Életkor
19 év to 70 év
People
10
Run by
CHA University
See details and how to joinNCT07143812
1/2. fázisTaking people
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma
Where
Incheon, Seongnam-si, Seoul
Életkor
18 év and over
People
43
Run by
Rznomics, Inc.
See details and how to joinNCT06102525
3. fázisTaking people
Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma
Where
Seoul
Életkor
70 év and over
People
178
Run by
Severance Hospital
See details and how to joinNCT05439278
1. fázisTaking people
A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
Where
Seoul
Életkor
19 év and over
People
12
Run by
BeyondBio Inc.
See details and how to joinNCT05769660
No phaseTaking people
Drug Response Testing and Repurposing Using Glioblastoma Organoid
Where
Daejeon
People
150
Run by
Chungnam National University Hospital
See details and how to joinNCT06782984